{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:46:18Z","timestamp":1789677978698,"version":"4.0.1"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary aldosteronism (PA) is the most common endocrine hypertension. For decades, PA diagnosis has required proving nonsuppressibility of aldosterone following maneuvers modulating the renin-angiotensin-aldosterone pathway. This includes oral salt suppression, intravenous saline suppression, captopril suppression, and others. Grounded in rational first principles from pathophysiologic considerations and small, early pathophysiologic studies following Conn\u2019s initial PA description, such testing has been widely recommended. However, a modern understanding of PA pathophysiology and critical appraisal of diagnostic test studies suggest that traditional suppression testing is not suited to diagnosis or disease definition. There are four main problems recently raised regarding aldosterone suppression testing: (i) PA is now known to exist along a continuous biochemical spectrum and it is scientifically impossible to draw a single, diagnostic threshold within this continuum. (ii) Aldosterone assay uncertainty is sufficiently large to yield contradictory final diagnoses when applied to a threshold during suppression testing. (iii) The pathophysiology of PA is multifactorial with multiple mechanisms not necessarily relevant to salt and volume loading tests. (iv) Finally, meta-analysis of suppression testing studies demonstrated extensive biases and confounders, which have overestimated the diagnostic value. A recent prospective, blinded study of saline suppression for PA diagnosis defined by medical or surgical response to PA-targeted therapy showed no discrimination according to nadir aldosterone level. Given the clinical value of a PA diagnosis and the high prevalence of the disease, modern evidence suggests that aldosterone suppression testing should now be retired from the diagnostic pathway; new ways of approaching the definition of PA are provided to spur further discussion.<\/jats:p>","DOI":"10.1093\/ajh\/hpaf163","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:33:11Z","timestamp":1756207991000},"page":"473-481","source":"Crossref","is-referenced-by-count":8,"title":["Is It Time to Retire Aldosterone Suppression Testing?"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9360","authenticated-orcid":false,"given":"Gregory A","family":"Kline","sequence":"first","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-8497","authenticated-orcid":false,"given":"Alexander A","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3014-3961","authenticated-orcid":false,"given":"Dennis","family":"Orton","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, BC Children\u2019s and Women\u2019s Hospital , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-2775","authenticated-orcid":false,"given":"James","family":"MacFarlane","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge & Cambridge University Hospitals NHS Foundation Trust , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-6832","authenticated-orcid":false,"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge & Cambridge University Hospitals NHS Foundation Trust , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026031200564497000_CIT0001","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MNH.0000000000000702","article-title":"How common is primary aldosteronism","volume":"30","author":"Hundemer","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026031200564497000_CIT0002","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026031200564497000_CIT0003","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"2026031200564497000_CIT0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"2026031200564497000_CIT0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026031200564497000_CIT0006","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1210\/clinem\/dgae039","article-title":"Health care challenges in the management of primary aldosteronism in Southeast Asia","volume":"109","author":"Sukor","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0007","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"key":"2026031200564497000_CIT0008","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.125.24648?download=true","article-title":"Nationwide, pragmatic, direct-to-patient primary aldosteronism testing program","volume":"82","author":"Brown","year":"2025","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2026031200564497000_CIT0009","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/ajh\/hpx064","article-title":"The potential role of primary care in case detection\/screening of primary aldosteronism","volume":"30","author":"Kline","year":"2017","journal-title":"Am J Hypertens"},{"key":"2026031200564497000_CIT0010","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","article-title":"Single dose captopril as a diagnostic test for primary aldosteronism","volume":"57","author":"Lyons","year":"1983 [","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0011","doi-asserted-by":"crossref","first-page":"e230445","DOI":"10.1530\/EC-23-0445","article-title":"Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism","volume":"13","author":"Jahan","year":"2024","journal-title":"Endocr Connect"},{"key":"2026031200564497000_CIT0012","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","article-title":"Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study","volume":"16","author":"Abdelhamid","year":"2003","journal-title":"American J Hypertens"},{"key":"2026031200564497000_CIT0013","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/circulationaha.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Brian Byrd","year":"2018","journal-title":"Circulation"},{"key":"2026031200564497000_CIT0014","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"2026031200564497000_CIT0016","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","article-title":"Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives","volume":"86","author":"Hirohara","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0017","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1210\/jcem.85.5.6596","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0018","first-page":"3","article-title":"Presidential address","volume":"45","author":"Conn","year":"1955","journal-title":"Transl Res"},{"key":"2026031200564497000_CIT0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"2026031200564497000_CIT0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic Primary Aldosteronism","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA - J Am Med Assoc"},{"key":"2026031200564497000_CIT0021","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9343(61)90080-8","article-title":"Studies on the expanded extracellular fluid and the responses to various stimuli in primary aldosteronism","volume":"30","author":"Biglieri","year":"1961","journal-title":"Am J Med"},{"key":"2026031200564497000_CIT0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jama.1961.03040400021004","article-title":"Useful parameters in the diagnosis of primary aldosteronism","volume":"178","author":"Biglieri","year":"1961","journal-title":"JAMA"},{"key":"2026031200564497000_CIT0023","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI105402","article-title":"Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease","volume":"45","author":"Cannon","year":"1966","journal-title":"J Clin Invest"},{"key":"2026031200564497000_CIT0024","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI106087","article-title":"Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism","volume":"48","author":"Horton","year":"1969","journal-title":"J Clin Invest"},{"key":"2026031200564497000_CIT0025","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2265.1975.tb01559.x","article-title":"Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension","volume":"4","author":"Padfield","year":"1975","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026031200564497000_CIT0026","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jama.1964.03070160037008","article-title":"Suppression of plasma renin activity in primary aldosteronism: distinguishing primary from secondary aldosteronism in hypertensive disease","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"2026031200564497000_CIT0027","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.HYP.15.6.547","article-title":"Abnormal pressure Natriuresis A cause or a consequence of hypertension","volume":"15","author":"Hall","year":"1990","journal-title":"Hypertension"},{"key":"2026031200564497000_CIT0028","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Resistant hypertension characterized by increased aldosterone levels and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026031200564497000_CIT0029","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJM197204202861603","article-title":"Dependence of arterial pressure on intravascular volume in treated hypertensive patients","volume":"286","author":"Dustan","year":"1972","journal-title":"N Engl J Med"},{"key":"2026031200564497000_CIT0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(75)90527-6","article-title":"The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension","volume":"58","author":"Laragh","year":"1975","journal-title":"Am J Med"},{"key":"2026031200564497000_CIT0031","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"2026031200564497000_CIT0032","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: an international human physiology study","volume":"109","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0033","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.124.24153","article-title":"Characterizing the origins of primary aldosteronism","volume":"82","author":"Brown","year":"2024","journal-title":"Hypertension"},{"key":"2026031200564497000_CIT0034","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"2026031200564497000_CIT0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2307\/2214170","article-title":"Sorites paradoxes and the semantics of vagueness","volume":"8","author":"Tye","year":"1994","journal-title":"Philos Perspect"},{"key":"2026031200564497000_CIT0036","doi-asserted-by":"crossref","first-page":"jc20151268","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0037","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2026031200564497000_CIT0038","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0039","first-page":"379","article-title":"Angiotensin II type 1 receptor autoantibodies in primary aldosteronism","volume":"52","author":"Meyer","year":"2025","journal-title":"Horm Metab Res"},{"key":"2026031200564497000_CIT0040","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2026031200564497000_CIT0041","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026031200564497000_CIT0042","doi-asserted-by":"publisher","first-page":"e924","DOI":"10.1210\/clinem\/dgaa272","article-title":"Classic and nonclassic apparent mineralocorticoid excess syndrome","volume":"105","author":"Carvaja","year":"2020","journal-title":"J Clin Endocrinol Metab [Internet]"},{"key":"2026031200564497000_CIT0043","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2026031200564497000_CIT0044","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/HJH.0000000000001905","article-title":"Surprisingly lowaldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: Implications for the concept of nonsuppressibility in primary aldosteronism","volume":"37","author":"Kline","year":"2019","journal-title":"J Hypertens"},{"key":"2026031200564497000_CIT0045","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ejendo\/lvae099","article-title":"Saline suppression testing-induced hypocalcemia and implications for clinical interpretations","volume":"191","author":"Parksook","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026031200564497000_CIT0046","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1515\/cclm.2011.733","article-title":"Reference change values","volume":"50","author":"Fraser","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"2026031200564497000_CIT0047","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0048","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","article-title":"Comparison of confirmatory tests for the diagnosis of primary aldosteronism","volume":"91","author":"Mulatero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0049","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism","volume":"97","author":"Nanba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0050","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"key":"2026031200564497000_CIT0051","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/HYPERTENSIONAHA.123.21983","article-title":"Long-term follow-up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes","volume":"81","author":"Buffolo","year":"2024","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2026031200564497000_CIT0052","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Intern Med"},{"key":"2026031200564497000_CIT0053","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026031200564497000_CIT0054","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","article-title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","volume":"13","author":"Yang","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026031200564497000_CIT0055","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0056","first-page":"51","volume-title":"Resistant Hypertension \u2013 Its Identification and Epidemiology","author":"Sarafidis","year":"2013"},{"key":"2026031200564497000_CIT0057","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"2026031200564497000_CIT0058","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41371-023-00891-1","article-title":"Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis","volume":"38","author":"Shah","year":"2024","journal-title":"J Hum Hypertens"},{"key":"2026031200564497000_CIT0059","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2026031200564497000_CIT0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjhyper.2005.06.010","article-title":"Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"2026031200564497000_CIT0061","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"Am J Hypertens"},{"key":"2026031200564497000_CIT0062","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1210\/jc.2013-3789","article-title":"Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism","volume":"122","author":"Riester","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0063","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.15225","article-title":"Tools to predict unilateral primary aldosteronism and optimise patient selection for adrenal vein sampling: a systematic review","volume":"103","author":"Ng","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026031200564497000_CIT0064","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"Jul 14","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0065","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026031200564497000_CIT0066","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajh\/hpad032","article-title":"Using renin activity to guide mineralocorticoid receptor antagonist therapy in patients with low renin and hypertension","volume":"36","author":"Mansur","year":"2023","journal-title":"Am J Hypertens"},{"key":"2026031200564497000_CIT0067","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2023","journal-title":"Endocr Rev"},{"key":"2026031200564497000_CIT0068","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0069","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1210\/clinem\/dgaa812","article-title":"Significance of discordant results between confirmatory tests in diagnosis of primary aldosteronism","volume":"106","author":"Fukumoto","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031200564497000_CIT0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"34","author":"Yozamp","year":"2021","journal-title":"Am J Hypertens"},{"key":"2026031200564497000_CIT0071","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf163\/64169787\/hpaf163.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/4\/473\/64169787\/hpaf163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/4\/473\/64169787\/hpaf163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:56:54Z","timestamp":1773291414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/39\/4\/473\/8244947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":71,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf163","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,8,28]]}}}